Overview

Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2028-09-01
Target enrollment:
Participant gender:
Summary
Dose\_dense Capecitabine Schedule in colorectal cancers
Phase:
PHASE2
Details
Lead Sponsor:
Sohag University
Treatments:
Capecitabine